Skip to main content

Table 3 Hematology

From: Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

Parameter Number of patients Before treatment After treatment Reference range P value Significance
Leukocytes (×109/L) 114 6.94 (1.57) 7.85 (2.25) 4.0-10.0 <0.001 In normal range but significantly elevated after treatment
Neutrophilic leukocytes % of total leukocytes 114 59.70 (10.39) 65.03 (13.06) 50.0-70.0 0.001 In normal range but significantly elevated after treatment
Lymphocytes % of total leukocytes 114 30.23 (9.20) 26.03 (10.32) 20.0-40.0 <0.001 In normal range but significantly decreased after treatment
RBC (×1012/L) 113 4.61 (0.51) 4.47 (0.46) 3.5-5.0 <0.001 In normal range but significantly decreased after treatment
Mean cell hemoglobin (g/L) 113 137.02 (14.54) 132.88 (13.98) 110.0-150.0 <0.001 In normal range but significantly decreased after treatment
Platelets (×109/L) 113 193.94 (47.64) 206.21 (54.52) 100.0-300.0 0.005 In normal range but significantly elevated after treatment